Detailed view for LmjF.36.4320

Basic information

TDR Targets ID: 22849
Leishmania major, hypothetical protein, conserved
Source Database / ID:  TriTrypDB  GeneDB

pI: 7.0793 | Length (AA): 2193 | MW (Da): 241368 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG2

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00168   C2 domain

Gene Ontology

Mouse over links to read term descriptions.
No GO information for this protein.

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 13 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
798 913 2chd (A) 382 507 19.00 0 0.43 0.33 -1.33
805 937 1wfj (A) 2 132 18.00 0 1 0.33 -0.68
1123 1248 1w15 (A) 288 417 18.00 0 0.26 0.16 -0.63
96 227 2kr0 (A) 179 290 35.00 0.21 0.02 -0.0121085 2.48
812 932 4iqh (A) 0 126 20.00 0 1 0.319476 -0.47
815 933 3kwu (A) 691 819 23.00 0 0.94 0.275564 -0.7
818 922 3kwt (A) 694 812 33.00 0.72 0.68 0.28058 0.19
1136 1239 2dmg (A) 20 133 29.00 0.43 0.25 0.254124 0.12
1516 1638 3kwu (A) 674 819 16.00 0.15 0.78 0.215188 -0.41
1522 1612 3jzy (A) 1544 1635 15.00 0.035 0.6 0.257596 -0.36
1530 1636 2ep6 (A) 108 214 15.00 0.11 0.81 0.179892 0.7
1740 1851 2d8k (A) 24 141 9.00 0.54 0.03 -0.0828284 1.17
1842 1955 4tm5 (A) 90 202 29.00 0.51 0.01 0.0986836 2.08

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile metacyclic. Fernandes MC
Upregulation Percent Ranking Stage Dataset
Lower 0-20% percentile amastigotes. Fernandes MC
Show/Hide expression data references
  • Fernandes MC Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures.

Orthologs

Ortholog group members (OG5_154094)

Species Accession Gene Product
Leishmania braziliensis LbrM.35.4560   hypothetical protein, conserved
Leishmania donovani LdBPK_364530.1   hypothetical protein, conserved
Leishmania infantum LinJ.36.4530   hypothetical protein, conserved
Leishmania major LmjF.36.4320   hypothetical protein, conserved
Leishmania mexicana LmxM.36.4320   hypothetical protein, conserved
Trypanosoma brucei gambiense Tbg972.10.11850   hypothetical protein, conserved
Trypanosoma brucei Tb927.10.9690   predicted C2 domain protein
Trypanosoma congolense TcIL3000_10_8660   predicted C2 domain protein
Trypanosoma cruzi TcCLB.504147.250   hypothetical protein, conserved

Essentiality

LmjF.36.4320 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.10.9690 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.10.9690 Trypanosoma brucei significant gain of fitness in bloodstream forms (6 days) alsford
Tb927.10.9690 Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.10.9690 Trypanosoma brucei significant gain of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model

Ranking Plot

Putative Drugs List

Compound Raw Global Species
0.0057 0.3491 0.5
0.0072 0.2639 1
0.0058 0.5 0.5
0.005 0.2612 0.5
0.0121 1 1
0.0125 0.3893 0.3893
0.0107 0.5 0.5
0.0018 0.5 0.5
0.0071 0.2549 1
0.0109 0.4866 0.5

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier LmjF.36.4320 (Leishmania major), hypothetical protein, conserved
Title for this comment
Comment